Insights

Innovative Diagnostic Technology PHASE Scientific offers proprietary tools like PHASIFY™ that significantly enhance the detection of target molecules, presenting an opportunity to sell advanced diagnostic instruments and reagents to laboratories, hospitals, and clinics seeking faster, more accurate testing solutions.

Expanding Testing Portfolio With successful launches of COVID-19 rapid tests and viral RNA extraction kits, the company demonstrates a capacity to develop versatile diagnostic products, opening sales avenues in infectious disease testing markets globally, especially amid ongoing health crises.

Strong Funding & Growth Recent Series A financing of $34 million coupled with a revenue range of up to $10 billion indicates robust financial health and scaling potential, making the company a promising partner for strategic collaborations or large-scale distribution deals.

Global Market Presence Headquartered in Hong Kong with operations in California and China's Greater Bay Area, PHASE Scientific is well-positioned to penetrate international markets, providing opportunities to expand sales channels across Asia, North America, and beyond.

Market Readiness & Recognition The company's emergency use authorizations and awards highlight its products' credibility and regulatory approval, making it easier to engage with healthcare providers and governments as a trusted supplier of rapid diagnostic solutions.

相达生物科技 Tech Stack

相达生物科技 uses 8 technology products and services including Open Graph, Cart Functionality, PWA, and more. Explore 相达生物科技's tech stack below.

  • Open Graph
    Content Management System
  • Cart Functionality
    E-commerce
  • PWA
    Miscellaneous
  • Yoast SEO
    Search Engines
  • HSTS
    Security
  • Plyr
    Video Players
  • Google Analytics
    Web Analytics
  • Formidable Forms
    Web Platform Extensions

Media & News

相达生物科技's Email Address Formats

相达生物科技 uses at least 2 format(s):
相达生物科技 Email FormatsExamplePercentage
First@phasediagnostics.comJohn@phasediagnostics.com
71%
Last@phasediagnostics.comDoe@phasediagnostics.com
29%

Frequently Asked Questions

What is 相达生物科技's official website and social media links?

Minus sign iconPlus sign icon
相达生物科技's official website is phasescientific.com and has social profiles on LinkedInCrunchbase.

What is 相达生物科技's SIC code NAICS code?

Minus sign iconPlus sign icon
相达生物科技's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does 相达生物科技 have currently?

Minus sign iconPlus sign icon
As of December 2025, 相达生物科技 has approximately 201 employees across 3 continents, including AsiaNorth AmericaOceania. Key team members include Chief Financial Officer: L. C.Vice President Of Commercial Operations: R. G.Head Of Business - Consumer Healthcare: E. Y.. Explore 相达生物科技's employee directory with LeadIQ.

What industry does 相达生物科技 belong to?

Minus sign iconPlus sign icon
相达生物科技 operates in the Biotechnology Research industry.

What technology does 相达生物科技 use?

Minus sign iconPlus sign icon
相达生物科技's tech stack includes Open GraphCart FunctionalityPWAYoast SEOHSTSPlyrGoogle AnalyticsFormidable Forms.

What is 相达生物科技's email format?

Minus sign iconPlus sign icon
相达生物科技's email format typically follows the pattern of First@phasediagnostics.com. Find more 相达生物科技 email formats with LeadIQ.

How much funding has 相达生物科技 raised to date?

Minus sign iconPlus sign icon
As of December 2025, 相达生物科技 has raised $34M in funding. The last funding round occurred on May 19, 2025 for $34M.

When was 相达生物科技 founded?

Minus sign iconPlus sign icon
相达生物科技 was founded in 2015.

相达生物科技

Biotechnology ResearchHong Kong Island, Hong Kong201-500 Employees

PHASE Scientific is a high-growth biotech company with a mission to inspire a new state of health. Headquartered in Hong Kong with locations in Southern California and China's Greater Bay Area, we provide novel diagnostic tools and services for cancer and infectious diseases with our proprietary technologies.

REVOLUTIONIZING HEALTHCARE THROUGH BETTER INSIGHT 

Better treatment starts with more timely and more precise detection, at the very beginning. 
 
Our proprietary technology, PHASIFY™, redefines the gold standard of diagnostics by making target molecules quicker and easier to detect. The technology, with the ability to concentrate target molecules by 10-100x, can help track down hidden conditions that are otherwise neglected, making diagnostics test more affordable, accessible, faster, easier, and more accurate.   

PHASIFY™ has a huge potential to be used in a wide range of applications. We are committed to further strengthening the research and development efforts to develop best-in-class screening and diagnostic tools and services in cancer and infectious diseases. Our aspiration is to support people in every step of their integrated healthcare journey, from early screening, diagnostics, treatment to ongoing monitoring, so as to make everyone healthier.

PRODUCTS AND SERVICES

INDICAID™ | At-home rapid tests that can be used anytime, anywhere
PHASE lab | Medical lab for cancer and infectious diseases, powered by PHASIFY™

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconFunding & Financials

  • $34M

    相达生物科技 has raised a total of $34M of funding over 3 rounds. Their latest funding round was raised on May 19, 2025 in the amount of $34M.

  • $1B$10B

    相达生物科技's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $34M

    相达生物科技 has raised a total of $34M of funding over 3 rounds. Their latest funding round was raised on May 19, 2025 in the amount of $34M.

  • $1B$10B

    相达生物科技's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.